Seven-year follow-up of a pediatric patient with combined hamartoma of retina and retinal pigment epithelium complicating with preretinal neovascularization and vitreous hemorrhage treated with intravitreal injections of bevacizumab
We report a case of successful management of intravitreal injections of anti-vascular endothelial growth factor antibody bevacizumab in two unusual complications, preretinal neovascularization and vitreous hemorrhage, secondary to a combined hamartoma of the retina and retinal pigment epithelium (CH...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2023-01-01
|
| Series: | Taiwan Journal of Ophthalmology |
| Subjects: | |
| Online Access: | http://www.e-tjo.org/article.asp?issn=2211-5056;year=2023;volume=13;issue=4;spage=556;epage=559;aulast=Tsai |
| _version_ | 1797226158730772480 |
|---|---|
| author | Tsung-Ying Tsai Kuan-Jen Chen An-Ning Chao |
| author_facet | Tsung-Ying Tsai Kuan-Jen Chen An-Ning Chao |
| author_sort | Tsung-Ying Tsai |
| collection | DOAJ |
| description | We report a case of successful management of intravitreal injections of anti-vascular endothelial growth factor antibody bevacizumab in two unusual complications, preretinal neovascularization and vitreous hemorrhage, secondary to a combined hamartoma of the retina and retinal pigment epithelium (CHRRPE). A male pediatric patient suffered from decreased vision in the right eye at 5-year-old. His ophthalmologic examination revealed a CHRRPE involving the superior area of the optic disc and macula in the right eye. The patient's family history and neurological examinations of tuberous sclerosis were absent. While no lesion growth was observed over time, preretinal vascularization and recurrent nonclearing hemorrhage occurred 2 years after the initial presentation. The patient was successfully managed with two intravitreal injections of bevacizumab. No recurrences of vitreous hemorrhage were observed at a 7-year post-treatment follow-up. Intravitreal injections of bevacizumab were safe and effective in the management of uncommon complications of preretinal neovascularization and vitreous hemorrhage of CHRRPE in a pediatric patient in long-term follow-up. |
| first_indexed | 2024-04-24T14:20:28Z |
| format | Article |
| id | doaj.art-6cb06e88160243c3af88e1ae8563718f |
| institution | Directory Open Access Journal |
| issn | 2211-5056 2211-5072 |
| language | English |
| last_indexed | 2024-04-24T14:20:28Z |
| publishDate | 2023-01-01 |
| publisher | Wolters Kluwer Medknow Publications |
| record_format | Article |
| series | Taiwan Journal of Ophthalmology |
| spelling | doaj.art-6cb06e88160243c3af88e1ae8563718f2024-04-03T06:45:05ZengWolters Kluwer Medknow PublicationsTaiwan Journal of Ophthalmology2211-50562211-50722023-01-0113455655910.4103/2211-5056.364566Seven-year follow-up of a pediatric patient with combined hamartoma of retina and retinal pigment epithelium complicating with preretinal neovascularization and vitreous hemorrhage treated with intravitreal injections of bevacizumabTsung-Ying TsaiKuan-Jen ChenAn-Ning ChaoWe report a case of successful management of intravitreal injections of anti-vascular endothelial growth factor antibody bevacizumab in two unusual complications, preretinal neovascularization and vitreous hemorrhage, secondary to a combined hamartoma of the retina and retinal pigment epithelium (CHRRPE). A male pediatric patient suffered from decreased vision in the right eye at 5-year-old. His ophthalmologic examination revealed a CHRRPE involving the superior area of the optic disc and macula in the right eye. The patient's family history and neurological examinations of tuberous sclerosis were absent. While no lesion growth was observed over time, preretinal vascularization and recurrent nonclearing hemorrhage occurred 2 years after the initial presentation. The patient was successfully managed with two intravitreal injections of bevacizumab. No recurrences of vitreous hemorrhage were observed at a 7-year post-treatment follow-up. Intravitreal injections of bevacizumab were safe and effective in the management of uncommon complications of preretinal neovascularization and vitreous hemorrhage of CHRRPE in a pediatric patient in long-term follow-up.http://www.e-tjo.org/article.asp?issn=2211-5056;year=2023;volume=13;issue=4;spage=556;epage=559;aulast=Tsaibevacizumabcombined hamartoma of the retina and retinal pigment epitheliumretinal neovascularizationvitreous hemorrhage |
| spellingShingle | Tsung-Ying Tsai Kuan-Jen Chen An-Ning Chao Seven-year follow-up of a pediatric patient with combined hamartoma of retina and retinal pigment epithelium complicating with preretinal neovascularization and vitreous hemorrhage treated with intravitreal injections of bevacizumab Taiwan Journal of Ophthalmology bevacizumab combined hamartoma of the retina and retinal pigment epithelium retinal neovascularization vitreous hemorrhage |
| title | Seven-year follow-up of a pediatric patient with combined hamartoma of retina and retinal pigment epithelium complicating with preretinal neovascularization and vitreous hemorrhage treated with intravitreal injections of bevacizumab |
| title_full | Seven-year follow-up of a pediatric patient with combined hamartoma of retina and retinal pigment epithelium complicating with preretinal neovascularization and vitreous hemorrhage treated with intravitreal injections of bevacizumab |
| title_fullStr | Seven-year follow-up of a pediatric patient with combined hamartoma of retina and retinal pigment epithelium complicating with preretinal neovascularization and vitreous hemorrhage treated with intravitreal injections of bevacizumab |
| title_full_unstemmed | Seven-year follow-up of a pediatric patient with combined hamartoma of retina and retinal pigment epithelium complicating with preretinal neovascularization and vitreous hemorrhage treated with intravitreal injections of bevacizumab |
| title_short | Seven-year follow-up of a pediatric patient with combined hamartoma of retina and retinal pigment epithelium complicating with preretinal neovascularization and vitreous hemorrhage treated with intravitreal injections of bevacizumab |
| title_sort | seven year follow up of a pediatric patient with combined hamartoma of retina and retinal pigment epithelium complicating with preretinal neovascularization and vitreous hemorrhage treated with intravitreal injections of bevacizumab |
| topic | bevacizumab combined hamartoma of the retina and retinal pigment epithelium retinal neovascularization vitreous hemorrhage |
| url | http://www.e-tjo.org/article.asp?issn=2211-5056;year=2023;volume=13;issue=4;spage=556;epage=559;aulast=Tsai |
| work_keys_str_mv | AT tsungyingtsai sevenyearfollowupofapediatricpatientwithcombinedhamartomaofretinaandretinalpigmentepitheliumcomplicatingwithpreretinalneovascularizationandvitreoushemorrhagetreatedwithintravitrealinjectionsofbevacizumab AT kuanjenchen sevenyearfollowupofapediatricpatientwithcombinedhamartomaofretinaandretinalpigmentepitheliumcomplicatingwithpreretinalneovascularizationandvitreoushemorrhagetreatedwithintravitrealinjectionsofbevacizumab AT anningchao sevenyearfollowupofapediatricpatientwithcombinedhamartomaofretinaandretinalpigmentepitheliumcomplicatingwithpreretinalneovascularizationandvitreoushemorrhagetreatedwithintravitrealinjectionsofbevacizumab |